VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,609,161 | -61.8% | 1,559,142 | 0.0% | 17.42% | -42.8% |
| Q2 2023 | $38,245,753 | +5.4% | 1,559,142 | 0.0% | 30.44% | -5.0% |
| Q1 2023 | $36,281,234 | -8.1% | 1,559,142 | 0.0% | 32.04% | +5.4% |
| Q4 2022 | $39,461,884 | +31.1% | 1,559,142 | 0.0% | 30.41% | +27.8% |
| Q3 2022 | $30,100,000 | -24.2% | 1,559,142 | 0.0% | 23.79% | -22.0% |
| Q2 2022 | $39,700,000 | -1.0% | 1,559,142 | 0.0% | 30.52% | +41.5% |
| Q1 2022 | $40,100,000 | +41.2% | 1,559,142 | +130.0% | 21.56% | +150.2% |
| Q4 2021 | $28,400,000 | -3.7% | 677,777 | 0.0% | 8.62% | -0.2% |
| Q3 2021 | $29,500,000 | -77.5% | 677,777 | -75.6% | 8.64% | -57.1% |
| Q2 2021 | $131,000,000 | -8.0% | 2,777,777 | 0.0% | 20.13% | -13.6% |
| Q1 2021 | $142,417,000 | +92.5% | 2,777,777 | 0.0% | 23.30% | +37.9% |
| Q4 2020 | $74,000,000 | – | 2,777,777 | – | 16.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |